GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Abbott India Ltd (NSE:ABBOTINDIA) » Definitions » EV-to-EBITDA

Abbott India (NSE:ABBOTINDIA) EV-to-EBITDA : 33.09 (As of Jun. 08, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Abbott India EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Abbott India's enterprise value is ₹563,017 Mil. Abbott India's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₹17,013 Mil. Therefore, Abbott India's EV-to-EBITDA for today is 33.09.

The historical rank and industry rank for Abbott India's EV-to-EBITDA or its related term are showing as below:

NSE:ABBOTINDIA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.39   Med: 25.29   Max: 43.9
Current: 33.09

During the past 13 years, the highest EV-to-EBITDA of Abbott India was 43.90. The lowest was 10.39. And the median was 25.29.

NSE:ABBOTINDIA's EV-to-EBITDA is ranked worse than
83.83% of 711 companies
in the Drug Manufacturers industry
Industry Median: 14.17 vs NSE:ABBOTINDIA: 33.09

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), Abbott India's stock price is ₹27494.80. Abbott India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹565.280. Therefore, Abbott India's PE Ratio for today is 48.64.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Abbott India EV-to-EBITDA Historical Data

The historical data trend for Abbott India's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott India EV-to-EBITDA Chart

Abbott India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.40 29.54 30.07 33.18 32.39

Abbott India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.18 33.75 30.83 29.97 32.39

Competitive Comparison of Abbott India's EV-to-EBITDA

For the Drug Manufacturers - General subindustry, Abbott India's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott India's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Abbott India's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Abbott India's EV-to-EBITDA falls into.



Abbott India EV-to-EBITDA Calculation

Abbott India's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=563016.601/17013.2
=33.09

Abbott India's current Enterprise Value is ₹563,017 Mil.
Abbott India's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹17,013 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott India  (NSE:ABBOTINDIA) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Abbott India's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=27494.80/565.280
=48.64

Abbott India's share price for today is ₹27494.80.
Abbott India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹565.280.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Abbott India EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Abbott India's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott India (NSE:ABBOTINDIA) Business Description

Traded in Other Exchanges
Address
15-16th Floor, Godrej BKC, Plot C-68, G Block, Near MCA Club, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Abbott India Ltd is a major drug manufacturing company that offers products offerings in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals. The vast majority of the company's revenue is generated in the India. The company's patient focus centers overwhelmingly toward women's health and gastrointestine, gastroenterology, and hepatic care. The company expects an increased use of collaboration with strategic partners as a component of its growth strategy.

Abbott India (NSE:ABBOTINDIA) Headlines

No Headlines